G9806 HCPCS Level II code: Patients who received cervical cytology or an hpv test
G9806 is the HCPCS code for “Patients who received cervical cytology or an hpv test” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
G9806Patients who received cervical cytology or an hpv test
Short description: Pt recd cerv cyto/hpv
HCPCS · United States
Medicare details
The indicators CMS publishes with G9806 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2017
Where G9806 sits
- 1G codesProcedures and professional services
- 2Active code G9806Patients who received cervical cytology or an hpv test
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code G9806 mean?
G9806 is the HCPCS code for “Patients who received cervical cytology or an hpv test” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover G9806?
CMS lists G9806’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9806
All G codesG9800Patients who are identified as having an intolerance or allergy to beta-blocker therapyG9801Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosisG9802Patients who use hospice services any time during the measurement periodG9803Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for amiG9804Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for amiG9805Patients who use hospice services any time during the measurement periodG9807Patients who did not receive cervical cytology or an hpv testG9808Any patients who had no asthma controller medications dispensed during the measurement yearG9809Patients who use hospice services any time during the measurement periodG9810Patient achieved a pdc of at least 75% for their asthma controller medicationG9811Patient did not achieve a pdc of at least 75% for their asthma controller medicationG9812Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge…